News We’re Watching – FDA Nixes Neuralink Trials, Layoffs at J&J, Novel Knee Implants
Executive Summary
This week, we learned that the US FDA thinks Elon Musk’s Neuralink brain interface device isn’t ready for human trials. Additionally, J&J cut about 300 medtech jobs, Stryker launched a knee implant, and Active Implants’ meniscus replacement device made it to the FDA’s advisory panel calendar.
You may also be interested in...
FDA Face Mask Guidance Updated To Reflect End Of PHE
A revised guidance for face masks and barrier face coverings changes the language of the title and text to reflect the end of the PHE.
News We’re Watching: Medtronic To Buy EOFLow, Neuralink Cleared For Human Trials, NICE Backs Genetic Tests
This week, Medtronic said it would pay $738m for insulin patch firm EOFlow; Neuralink got an FDA OK for first-in-human trials; and UK agency NICE backed genetic tests for stroke patients and digital therapeutics for mental health conditions.
Reducing Antimicrobial Resistance With Rapid Tests
Widespread implementation of rapid diagnostic tests is critical for decreasing antimicrobial resistance.